Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Core Laboratories
CLB
$571M
| $19.4M | 0.01% |
177,096
+160,265
| +952% | +$16M |
|
1102
Red Robin
RRGB
$192M
| $19.4M | 0.01% |
343,554
+97,615
| +40% | +$5.62M |
|
1103
PUT
Becton Dickinson
BDX
$50B
| $19.4M | 0.01% |
92,763
+44,895
| +94% | +$9.4M |
|
1104
CALL
Take-Two Interactive
TTWO
$46.2B
| $19.4M | 0.01% |
176,400
+5,100
| +3% | +$557K |
|
1105
Antero Midstream
AM
$10.7B
| $19.4M | 0.01% |
981,321
+502,552
| +105% | +$9.34M |
|
1106
BlackBerry
BB
$5.22B
| $19.3M | 0.01% |
1,730,762
+1,313,306
| +315% | +$14.3M |
|
1107
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$342M
| $19.3M | 0.01% |
167,200
-158,100
| -49% | -$18M |
|
1108
PUT
MetLife
MET
$62.1B
| $19.3M | 0.01% |
382,200
+180,100
| +89% | +$9.49M |
|
1109
Pentair
PNR
$10.6B
| $19.3M | 0.01% |
407,250
+90,565
| +29% | +$4.23M |
|
|
CAVM
1110
DELISTED
Cavium, Inc.
CAVM
| $19.3M | 0.01% |
230,246
-321,577
| -58% | -$24.9M |
|
1111
PUT
Ally Financial
ALLY
$13.7B
| $19.2M | 0.01% |
658,200
+111,000
| +20% | +$2.95M |
|
1112
PUT
First Solar
FSLR
$24.2B
| $19.1M | 0.01% |
283,500
-149,000
| -34% | -$8.74M |
|
1113
Urban Outfitters
URBN
$6.66B
| $19.1M | 0.01% |
545,838
-1,489,613
| -73% | -$41.7M |
|
1114
PUT
Thermo Fisher Scientific
TMO
$218B
| $19M | 0.01% |
100,300
+25,000
| +33% | +$4.79M |
|
1115
Huntington Ingalls Industries
HII
$12.9B
| $19M | 0.01% |
80,549
+73,921
| +1,115% | +$17.4M |
|
1116
Molson Coors Class B
TAP
$7.97B
| $19M | 0.01% |
231,121
-42,895
| -16% | -$3.47M |
|
1117
Blackrock
BLK
$182B
| $19M | 0.01% |
36,905
-127,634
| -78% | -$62M |
|
1118
CALL
Cummins
CMI
$86.9B
| $19M | 0.01% |
107,300
-17,600
| -14% | -$3.01M |
|
|
K
1119
PUT
DELISTED
Kellanova
K
| $19M | 0.01% |
296,922
-18,531
| -6% | -$1.12M |
|
|
RHT
1120
CALL
DELISTED
Red Hat Inc
RHT
| $19M | 0.01% |
157,800
+43,600
| +38% | +$5.34M |
|
1121
Cigna
CI
$74.7B
| $18.9M | 0.01% |
93,212
+69,592
| +295% | +$13.9M |
|
1122
PUT
Ford
F
$57.3B
| $18.9M | 0.01% |
1,514,300
+602,800
| +66% | +$7.42M |
|
1123
PUT
PVH
PVH
$3.8B
| $18.8M | 0.01% |
136,900
+36,800
| +37% | +$4.81M |
|
1124
CALL
Herbalife
HLF
$1.29B
| $18.8M | 0.01% |
554,000
-4,200
| -0.8% | -$147K |
|
|
K
1125
DELISTED
Kellanova
K
| $18.6M | 0.01% |
291,840
-1,017,916
| -78% | -$61.3M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.